Monoclonal Antibody Therapy in Neuromyelitis Optica Spectrum Disorders: a Meta-analysis of Randomized Control Trials

Background: To update the efficacy and safety data of monoclonal antibodies for the treatment of neuromyelitis optica spectrum disorders (NMOSD) and explore the differences in the effect of treatment between patients seropositive and seronegative for AQP4-IgG. Methods: PubMed, Embase, and the Cochra...

Descripción completa

Detalles Bibliográficos
Autores principales: Kong, Fanxin, Wang, Jianjun, Zheng, Haotao, Cai, Haobin, Hua, Jun, Li, Liling
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8329455/
https://www.ncbi.nlm.nih.gov/pubmed/34354581
http://dx.doi.org/10.3389/fphar.2021.652759

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8329455/
https://www.ncbi.nlm.nih.gov/pubmed/34354581
http://dx.doi.org/10.3389/fphar.2021.652759

Ejemplares similares